BCIQ Profiles

Company Profile Report
0421 QT Fin
BioCentury & Getty Images


April 21 Quick Takes: $50M for Sense Biodetection to expand portfolio; plus semaglutide, Porton, Seed Health, Rinri, Mestag, Lyndra

Apr 22, 2021 | 12:30 AM GMT

A $50 million series B round led by Koch Disruptive Technologies positions Sense Biodetection Ltd. to launch its Veros COVID-19 molecular test

Read the full 505 word article

How to gain access

Continue reading with a
two-week free trial.